News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
667,415 Results
Type
Article (33884)
Company Profile (641)
Press Release (632890)
Multimedia
Podcasts (87)
Webinars (12)
Section
Business (202160)
Career Advice (2188)
Deals (36965)
Drug Delivery (109)
Drug Development (80292)
Employer Resources (167)
FDA (15658)
Job Trends (15022)
News (341874)
Policy (30016)
Tag
Academia (1325)
Academic (1)
Accelerated approval (5)
Adcomms (15)
Allergies (87)
Alliances (48379)
ALS (98)
Alzheimer's disease (1322)
Antibody-drug conjugate (ADC) (151)
Approvals (15634)
Artificial intelligence (269)
Autoimmune disease (29)
Automation (15)
Bankruptcy (380)
Best Places to Work (11055)
BIOSECURE Act (22)
Biosimilars (105)
Biotechnology (438)
Bladder cancer (77)
Brain cancer (26)
Breast cancer (254)
Cancer (2172)
Cardiovascular disease (179)
Career advice (1806)
Career pathing (32)
CAR-T (154)
Cell therapy (446)
Cervical cancer (18)
Clinical research (65874)
Collaboration (879)
Company closure (2)
Compensation (564)
Complete response letters (29)
COVID-19 (2229)
CRISPR (48)
C-suite (268)
Cystic fibrosis (102)
Data (2207)
Decentralized trials (2)
Denatured (16)
Depression (52)
Diabetes (258)
Diagnostics (6356)
Digital health (17)
Diversity (3)
Diversity, equity & inclusion (38)
Drug discovery (117)
Drug pricing (111)
Drug shortages (27)
Duchenne muscular dystrophy (92)
Earnings (85645)
Editorial (41)
Employer branding (24)
Employer resources (142)
Events (112617)
Executive appointments (763)
FDA (16954)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (762)
Gene editing (119)
Generative AI (25)
Gene therapy (322)
GLP-1 (748)
Government (3046)
Grass and pollen (6)
Guidances (142)
Healthcare (16043)
Huntington's disease (24)
IgA nephropathy (29)
Immunology and inflammation (135)
Indications (29)
Infectious disease (2369)
Inflammatory bowel disease (143)
Inflation Reduction Act (9)
Influenza (52)
Intellectual property (99)
Interviews (435)
IPO (17344)
IRA (45)
Job creations (4407)
Job search strategy (1505)
Kidney cancer (10)
Labor market (42)
Layoffs (551)
Leadership (19)
Legal (7596)
Liver cancer (74)
Lung cancer (308)
Lymphoma (141)
Machine learning (6)
Management (59)
Manufacturing (349)
MASH (77)
Medical device (13547)
Medtech (13552)
Mergers & acquisitions (20194)
Metabolic disorders (703)
Multiple sclerosis (85)
NASH (21)
Neurodegenerative disease (103)
Neuropsychiatric disorders (32)
Neuroscience (1894)
NextGen: Class of 2025 (6021)
Non-profit (2028)
Now hiring (41)
Obesity (376)
Opinion (253)
Ovarian cancer (72)
Pain (103)
Pancreatic cancer (85)
Parkinson's disease (148)
Partnered (19)
Patents (249)
Patient recruitment (113)
Peanut (48)
People (57913)
Pharmaceutical (133)
Pharmacy benefit managers (18)
Phase I (20608)
Phase II (29348)
Phase III (21805)
Pipeline (1354)
Policy (150)
Postmarket research (2119)
Preclinical (8435)
Press Release (64)
Prostate cancer (104)
Psychedelics (36)
Radiopharmaceuticals (261)
Rare diseases (397)
Real estate (5972)
Recruiting (65)
Regulatory (21411)
Reports (36)
Research institute (1388)
Resumes & cover letters (342)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (79)
Series A (138)
Series B (93)
Service/supplier (26)
Sickle cell disease (55)
Special edition (18)
Spinal muscular atrophy (148)
Sponsored (22)
Startups (3922)
State (2)
Stomach cancer (13)
Supply chain (72)
Tariffs (54)
The Weekly (69)
Vaccines (673)
Venture capitalists (45)
Weight loss (255)
Women's health (26)
Worklife (20)
Date
Last 7 days (941)
Last 30 days (2978)
Last 365 days (32860)
2025 (11836)
2024 (35880)
2023 (40633)
2022 (50954)
2021 (54253)
2020 (51307)
2019 (42416)
2018 (32401)
2017 (32980)
2016 (31304)
2015 (36752)
2014 (29893)
2013 (24994)
2012 (26563)
2011 (26770)
2010 (24700)
Location
Africa (690)
Alabama (60)
Alaska (6)
Arizona (173)
Arkansas (11)
Asia (41576)
Australia (6657)
California (6474)
Canada (2054)
China (548)
Colorado (271)
Connecticut (285)
Delaware (150)
Europe (89461)
Florida (906)
Georgia (210)
Hawaii (1)
Idaho (56)
Illinois (485)
India (28)
Indiana (331)
Iowa (12)
Japan (164)
Kansas (102)
Kentucky (24)
Louisiana (12)
Maine (65)
Maryland (816)
Massachusetts (4980)
Michigan (239)
Minnesota (406)
Mississippi (2)
Missouri (80)
Montana (30)
Nebraska (22)
Nevada (62)
New Hampshire (66)
New Jersey (1800)
New Mexico (30)
New York (1780)
North Carolina (1091)
North Dakota (7)
Northern California (2812)
Ohio (193)
Oklahoma (10)
Oregon (41)
Pennsylvania (1393)
Puerto Rico (14)
Rhode Island (35)
South America (1089)
South Carolina (24)
South Dakota (1)
Southern California (2384)
Tennessee (85)
Texas (929)
United States (23992)
Utah (182)
Virginia (150)
Washington D.C. (62)
Washington State (582)
West Virginia (3)
Wisconsin (57)
667,415 Results for "dupont pharmaceuticals company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
MaaT Pharma Announces Initiation of Coverage of its Stock by Gilbert Dupont/ Groupe Société Générale
MaaT Pharma, a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM dedicated to enhancing survival of patients with cancer, announces the initiation of coverage of its stock by Gilbert Dupont.
April 5, 2024
·
2 min read
Business
DuPont Announces Regular Quarterly Dividend on Common Stock - October 17, 2023
DuPont announced that its Board of Directors has declared a third quarter dividend of thirty-six cents per share on the outstanding Common Stock of the Company payable on December 15, 2023, to holders of record of said stock at the close of business on November 30, 2023.
October 17, 2023
·
1 min read
Pharm Country
Qosina Teams up with DuPont™ Liveo™ Healthcare Solutions to Market Its Liveo™ Biopharmaceutical-grade Tubing
Qosina is pleased to announce it has teamed up with DuPont™ Liveo™ Healthcare Solutions, a leader in the innovative design and production of solutions for biopharmaceutical, pharmaceutical and medical device markets.
April 20, 2023
·
5 min read
Press Releases
Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
April 29, 2025
·
3 min read
Press Releases
Taiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris Biotech
March 17, 2025
·
7 min read
Press Releases
CASI Pharmaceuticals Announces Receipt of An Updated Non-Binding Proposal to Acquire Entire China Business of the Company
April 3, 2025
·
7 min read
Press Releases
Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company’s Single-Dose Mpox and Smallpox Vaccine Candidate
March 10, 2025
·
10 min read
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
May 1, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.
December 30, 2024
·
11 min read
Press Releases
Organon Appoints Ramona A. Sequeira to the Company’s Board of Directors
April 15, 2025
·
2 min read
1 of 66,742
Next
